Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Walgaard, C"'
Autor:
Luijten, L.W.G., Doets, A.Y., Arends, S., Dimachkie, M.M., Gorson, K.C., Islam, B., Kolb, N.A., Kusunoki, S., Papri, N., Waheed, W., Walgaard, C., Yamagishi, Y., Lingsma, H., Jacobs, B.C., IGOS Consortium
Publikováno v:
Journal of Neurology, Neurosurgery and Psychiatry. BMJ PUBLISHING GROUP
Journal of Neurology, Neurosurgery and Psychiatry
Journal of Neurology, Neurosurgery and Psychiatry, 94(4):329937, 300-308. BMJ Publishing Group
Luijten, L W G, Doets, A Y, Arends, S, Dimachkie, M M, Gorson, K C, Islam, B, Kolb, N A, Kusunoki, S, Papri, N, Waheed, W, Walgaard, C, Yamagishi, Y, Lingsma, H, Jacobs, B C & IGOS Consortium 2023, ' Modified Erasmus GBS Respiratory Insufficiency Score : a simplified clinical tool to predict the risk of mechanical ventilation in Guillain-Barré syndrome ', Journal of neurology, neurosurgery, and psychiatry, vol. 94, no. 4, pp. 300-308 . https://doi.org/10.1136/jnnp-2022-329937
Journal of Neurology, Neurosurgery and Psychiatry
Journal of Neurology, Neurosurgery and Psychiatry, 94(4):329937, 300-308. BMJ Publishing Group
Luijten, L W G, Doets, A Y, Arends, S, Dimachkie, M M, Gorson, K C, Islam, B, Kolb, N A, Kusunoki, S, Papri, N, Waheed, W, Walgaard, C, Yamagishi, Y, Lingsma, H, Jacobs, B C & IGOS Consortium 2023, ' Modified Erasmus GBS Respiratory Insufficiency Score : a simplified clinical tool to predict the risk of mechanical ventilation in Guillain-Barré syndrome ', Journal of neurology, neurosurgery, and psychiatry, vol. 94, no. 4, pp. 300-308 . https://doi.org/10.1136/jnnp-2022-329937
BackgroundThis study aimed to determine the clinical and diagnostic factors associated with mechanical ventilation (MV) in Guillain-Barré syndrome (GBS) and to simplify the existing Erasmus GBS Respiratory Insufficiency Score (EGRIS) for predicting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::064ed7c4be38d9ac951261921e5a3c89
http://hdl.handle.net/1887/3505448
http://hdl.handle.net/1887/3505448
Autor:
Doets, A.Y., Lingsma, H.F., Walgaard, C., Islam, B., Papri, N., Davidson, A., Yamagishi, Y., Kusunoki, S., Dimachkie, M.M., Waheed, W., Kolb, N., Islam, Z., Mohammad, Q.D., Harbo, T., Sindrup, S.H., Chavada, G., Willison, H.J., Casasnovas, C., Bateman, K., Miller, J.A.L., Berg, B. van den, Verboon, C., Roodbol, J., Leonhard, S.E., Benedetti, L., Kuwabara, S., Bergh, P. van den, Monges, S., Marfia, G.A., Shahrizaila, N., Galassi, G., Pereon, Y., Burmann, J., Kuitwaard, K., Kleyweg, R.P., Marchesoni, C., Tous, M.J.S., Querol, L., Illa, I., Wang, Y.Z., Nobile-Orazio, E., Rinaldi, S., Schenone, A., Pardo, J., Vermeij, F.H., Lehmann, H.C., Granit, V., Cavaletti, G., Gutierrez-Gutierrez, G., Barroso, F.A., Visser, L.H., Katzberg, H.D., Dardiotis, E., Attarian, S., Kooi, A.J. van der, Eftimov, F., Wirtz, P.W., Samijn, J.P.A., Gilhuis, H.J., Hadden, R.D.M., Holt, J.K.L., Sheikh, K.A., Karafiath, S., Vytopil, M., Antonini, G., Feasby, T.E., Faber, C.G., Gijsbers, C.J., Busby, M., Roberts, R.C., Silvestri, N.J., Fazio, R., Dijk, G.W. van, Garssen, M.P.J., Straathof, C.S.M., Gorson, K.C., Jacobs, B.C., IGOS Consortium
Publikováno v:
Neurology, 98(5), E518-E532. Lippincott Williams and Wilkins
Neurology, 98(5), E518-E532. LIPPINCOTT WILLIAMS & WILKINS
Neurology, 98(5), E518-E532. Lippincott Williams & Wilkins
Doets, A Y, Lingsma, H F, Walgaard, C, Islam, B, Papri, N, Davidson, A, Yamagishi, Y, Kusunoki, S, Dimachkie, M M, Waheed, W, Kolb, N, Islam, Z, Mohammad, Q D, Harbo, T, Sindrup, S H, Chavada, G, Willison, H J, Casasnovas, C, Bateman, K, Miller, J A L, van den Berg, B, Verboon, C, Roodbol, J, Leonhard, S E, Benedetti, L, Kuwabara, S, van den Bergh, P, Monges, S, Marfia, G A, Shahrizaila, N, Galassi, G, Péréon, Y, Bürmann, J, Kuitwaard, K, Kleyweg, R P, Marchesoni, C, Sedano Tous, M J, Querol, L, Illa, I, Wang, Y, Nobile-Orazio, E, Rinaldi, S, Schenone, A, Pardo, J, Vermeij, F H, Lehmann, H C, Granit, V, Cavaletti, G, Gutiérrez-Gutiérrez, G, Barroso, F A & the IGOS consortium 2022, ' Predicting Outcome in Guillain-Barré Syndrome : International Validation of the Modified Erasmus GBS Outcome Score ', Neurology, vol. 98, no. 5, pp. E518-E532 . https://doi.org/10.1212/WNL.0000000000013139
Doets, A Y, Lingsma, H F, Walgaard, C, Islam, B, Papri, N, Davidson, A, Yamagishi, Y, Kusunoki, S, Dimachkie, M M, Waheed, W, Kolb, N, Islam, Z, Mohammad, Q D, Harbo, T, Sindrup, S H, Chavada, G, Willison, H J, Casasnovas, C, Bateman, K, Miller, J A L, van den Berg, B, Verboon, C, Roodbol, J, Leonhard, S E, Benedetti, L, Kuwabara, S, van den Bergh, P, Monges, S, Marfia, G A, Shahrizaila, N, Galassi, G, Péréon, Y, Bürmann, J, Kuitwaard, K, Kleyweg, R P, Marchesoni, C, Sedano Tous, M J, Querol, L, Illa, I, Wang, Y, Nobile-Orazio, E, Rinaldi, S, Schenone, A, Pardo, J, Vermeij, F H, Lehmann, H C, Granit, V, Cavaletti, G, Gutiérrez-Gutiérrez, G, Barroso, F A & the IGOS Consortium 2022, ' Predicting Outcome in Guillain-Barré Syndrome International Validation of the Modified Erasmus GBS Outcome Score ', Neurology, vol. 98, no. 5, pp. E518-E532 . https://doi.org/10.1212/WNL.0000000000013139
Neurology
Neurology, 98(5), E518-E532. LIPPINCOTT WILLIAMS & WILKINS
Neurology, 98(5), E518-E532. Lippincott Williams & Wilkins
Doets, A Y, Lingsma, H F, Walgaard, C, Islam, B, Papri, N, Davidson, A, Yamagishi, Y, Kusunoki, S, Dimachkie, M M, Waheed, W, Kolb, N, Islam, Z, Mohammad, Q D, Harbo, T, Sindrup, S H, Chavada, G, Willison, H J, Casasnovas, C, Bateman, K, Miller, J A L, van den Berg, B, Verboon, C, Roodbol, J, Leonhard, S E, Benedetti, L, Kuwabara, S, van den Bergh, P, Monges, S, Marfia, G A, Shahrizaila, N, Galassi, G, Péréon, Y, Bürmann, J, Kuitwaard, K, Kleyweg, R P, Marchesoni, C, Sedano Tous, M J, Querol, L, Illa, I, Wang, Y, Nobile-Orazio, E, Rinaldi, S, Schenone, A, Pardo, J, Vermeij, F H, Lehmann, H C, Granit, V, Cavaletti, G, Gutiérrez-Gutiérrez, G, Barroso, F A & the IGOS consortium 2022, ' Predicting Outcome in Guillain-Barré Syndrome : International Validation of the Modified Erasmus GBS Outcome Score ', Neurology, vol. 98, no. 5, pp. E518-E532 . https://doi.org/10.1212/WNL.0000000000013139
Doets, A Y, Lingsma, H F, Walgaard, C, Islam, B, Papri, N, Davidson, A, Yamagishi, Y, Kusunoki, S, Dimachkie, M M, Waheed, W, Kolb, N, Islam, Z, Mohammad, Q D, Harbo, T, Sindrup, S H, Chavada, G, Willison, H J, Casasnovas, C, Bateman, K, Miller, J A L, van den Berg, B, Verboon, C, Roodbol, J, Leonhard, S E, Benedetti, L, Kuwabara, S, van den Bergh, P, Monges, S, Marfia, G A, Shahrizaila, N, Galassi, G, Péréon, Y, Bürmann, J, Kuitwaard, K, Kleyweg, R P, Marchesoni, C, Sedano Tous, M J, Querol, L, Illa, I, Wang, Y, Nobile-Orazio, E, Rinaldi, S, Schenone, A, Pardo, J, Vermeij, F H, Lehmann, H C, Granit, V, Cavaletti, G, Gutiérrez-Gutiérrez, G, Barroso, F A & the IGOS Consortium 2022, ' Predicting Outcome in Guillain-Barré Syndrome International Validation of the Modified Erasmus GBS Outcome Score ', Neurology, vol. 98, no. 5, pp. E518-E532 . https://doi.org/10.1212/WNL.0000000000013139
Neurology
Background and ObjectivesThe clinical course and outcome of the Guillain-Barré syndrome (GBS) are diverse and vary among regions. The modified Erasmus GBS Outcome Score (mEGOS), developed with data from Dutch patients, is a clinical model that predi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37779cf9507298a6202d42c62178d160
https://hdl.handle.net/1887/3495929
https://hdl.handle.net/1887/3495929
Autor:
Luijten, LWG, Leonhard, SE, van der Eijk, AA, Doets, AY, Appeltshauser, L, Arends, S, Attarian, S, Benedetti, L, Briani, C, Casasnovas, C, Castellani, F, Dardiotis, E, Echaniz-Laguna, A, Garssen, MPJ, Harbo, T, Huizinga, R, Humm, AM, Jellema, K, van der Kooi, AJ, Kuitwaard, K, Kuntzer, T, Kusunoki, S, Lascano, AM, Martinez-Hernandez, E, Rinaldi, S, Samijn, JPA, Scheidegger, O, Tsouni, P, Vicino, A, Visser, LH, Walgaard, C, Wang, YZ, Wirtz, PW, Ripellino, P, Jacobs, BC, Martín-Aguilar L, Zivkovic, Sasa A.
Publikováno v:
Luijten, Linda W G; Leonhard, Sonja E; van der Eijk, Annemiek A; Doets, Alex Y; Appeltshauser, Luise; Arends, Samuel; Attarian, Shahram; Benedetti, Luana; Briani, Chiara; Casasnovas, Carlos; Castellani, Francesca; Dardiotis, Efthimios; Echaniz-Laguna, Andoni; Garssen, Marcel P J; Harbo, Thomas; Huizinga, Ruth; Humm, Andrea M; Jellema, Korné; van der Kooi, Anneke J; Kuitwaard, Krista; ... (2021). Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study. Brain : a journal of neurology, 144(11), pp. 3392-3404. Oxford University Press 10.1093/brain/awab279
BRAIN
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Brain, 144, 3392-3404. OXFORD UNIV PRESS
Brain, 144(11), 3392-3404. Oxford University Press
Dipòsit Digital de la UB
Universidad de Barcelona
Brain
IGOS Consortium 2021, ' Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study ', Brain : a journal of neurology, vol. 144, no. 11, pp. 3392-3404 . https://doi.org/10.1093/brain/awab279
BRAIN
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Brain, 144, 3392-3404. OXFORD UNIV PRESS
Brain, 144(11), 3392-3404. Oxford University Press
Dipòsit Digital de la UB
Universidad de Barcelona
Brain
IGOS Consortium 2021, ' Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study ', Brain : a journal of neurology, vol. 144, no. 11, pp. 3392-3404 . https://doi.org/10.1093/brain/awab279
In the wake of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, an increasing number of patients with neurological disorders, including Guillain-Barré syndrome (GBS), have been reported following this infection. It remains
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0d4d4e953504adedbb9f0662cad6a67
https://boris.unibe.ch/160834/1/Luijten__2021__GBS_after_SARS-COV-2_infection.pdf
https://boris.unibe.ch/160834/1/Luijten__2021__GBS_after_SARS-COV-2_infection.pdf
Autor:
Luijten, L, Leonhard, S, Doets, A, van der Eijk, A, Appeltshauser, L, Arends, S, Attarian, S, Benedetti, L, Briani, C, Casasnovas, C, Castellani, F, Dardiotis, E, Echaniz-Laguna, A, Harbo, T, Humm, A, Garssen, M, Huizinga, R, Jellema, K, van der Kooi, A, Kuitwaard, K, Kuntzer, T, Kusunoki, S, Lascano, A, Martinez-Hernandez, E, Samijn, J, Rinaldi, S, Scheidegger, O, Tsouni, P, Vicino, A, Visser, L, Walgaard, C, Wang, Y, Wirtz, P, Ripellino, P, Jacobs, B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1064::609656643cee3061de43d44597d2fb6f
https://doi.org/10.1111/jns.12460
https://doi.org/10.1111/jns.12460
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Doets, Ay, Walgaard, C, Lingsma, Hf, Islam, B, Papri, N, Yamagishi, Y, Kusunoki, S, Dimachkie, Mm, Waheed, W, Kolb, N, Gorson, Kc, Jacobs, Bart, C, Marfia, Ga
Publikováno v:
Annals of Neurology, 91(4), 521-531. John Wiley & Sons Inc.
Annals of neurology, 91(4), 521-531. John Wiley and Sons Inc.
Doets, A Y, Walgaard, C, Lingsma, H F, Islam, B, Papri, N, Yamagishi, Y, Kusunoki, S, Dimachkie, M M, Waheed, W, Kolb, N, Gorson, K C, Jacobs, B C & IGOS Consortium 2022, ' International Validation of the Erasmus Guillain-Barré Syndrome Respiratory Insufficiency Score ', Annals of Neurology, vol. 91, no. 4, pp. 521-531 . https://doi.org/10.1002/ana.26312
Annals of Neurology, 91(4), 521-531. WILEY
Annals of neurology, 91(4), 521-531. John Wiley and Sons Inc.
Doets, A Y, Walgaard, C, Lingsma, H F, Islam, B, Papri, N, Yamagishi, Y, Kusunoki, S, Dimachkie, M M, Waheed, W, Kolb, N, Gorson, K C, Jacobs, B C & IGOS Consortium 2022, ' International Validation of the Erasmus Guillain-Barré Syndrome Respiratory Insufficiency Score ', Annals of Neurology, vol. 91, no. 4, pp. 521-531 . https://doi.org/10.1002/ana.26312
Annals of Neurology, 91(4), 521-531. WILEY
Objective:This study aimed to validate the Erasmus Guillain–Barré Syndrome Respiratory Insufficiency Score in the International Guillain–Barré Syndrome Outcome Study cohort, and to improve its performance and region-specificity. Methods:We exam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a54ffc3fd39da1d0192460bd41df612b
https://pure.eur.nl/en/publications/233421eb-b624-4fe1-a771-823725c694ba
https://pure.eur.nl/en/publications/233421eb-b624-4fe1-a771-823725c694ba
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Rinaldi, S, Brennan, KM, Kalna, G, Walgaard, C, Van Doorn, P, Jacobs, BC, Yu, RK, Mansson, JE, Goodyear, CS, Willison, HJ
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e82337 (2013)
PLoS One (print), 8(12). Public Library of Science
PLoS One (print), 8(12). Public Library of Science
Autoantibodies are infrequently detected in the sera of patients with the demyelinating form of Guillain-Barré syndrome most commonly encountered in the Western world, despite abundant circumstantial evidence suggesting their existence. We hypothesi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::e835adf9d7d2f564502aa21a9a1ef78f
https://ora.ox.ac.uk/objects/uuid:2fe683d6-86c0-4cfe-ba7f-4b82a266fc1e
https://ora.ox.ac.uk/objects/uuid:2fe683d6-86c0-4cfe-ba7f-4b82a266fc1e